IGIBvsWDNA
iShares 5-10 Year Investment Grade Corporate Bond ETF against WisdomTree BioRevolution Fund — the fee, the flows, the book, and a year head-to-head.
Head to head
| IGIB | WDNA | |
|---|---|---|
| Expense ratio | 0.040% | 0.45% |
| Assets | $18.6B | $2534.72T |
| Net flow, 1 month | +$565M | — |
| Net flow, 1 year | +$3.6B | — |
| Return, YTD | -6.9% | +40.3% |
| Return, 1 year | -7.3% | +41.7% |
| Avg daily volume | 3.8M | 4K |
| Holdings | 2744 | 91 |
| Listed | Jan 5, 2007 | Jun 3, 2021 |
| Options market | Yes | Yes |
MARKED CELLS LEAD ON THAT LINE · LOWER FEE, LARGER ASSETS, STRONGER FLOWS & RETURNS